Timo Hautala

Dr. Timo Hautala


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2014 in Neurology
Verified
Journal Article
Closed access
PDF file
HLHye Kyung Lim
Hye Kyung Lim
MSMikko Seppänen
Mikko Seppänen
THTimo Hautala
Timo Hautala
MCMichael J. Ciancanelli
Michael J. Ciancanelli
YIYuval Itan
Yuval Itan
SZShen-Ying Zhang
Shen-Ying Zhang
Objective: To determine the proportion of children with herpes simplex encephalitis (HSE) displaying TLR3 deficiency, the extent of TLR3 allelic heterogeneity, and the specific clinical features of TLR3 deficiency. Methods: We determined the sequence of all exons of TLR3 in 110 of the 120 patients with HSE enrolled in our study who do not carry any of the previously described HSE-predisposing mutations of TLR3 pathway genes (TLR3, UNC93B1, TRIF, TRAF3, and TBK1). All the new mutant TLR3 alleles detected were characterized experimentally in-depth to establish the causal relationship between the genotype and phenotype. Results: In addition to the 3 previously reported TLR3-deficient patients from the same cohort, 6 other children or young adults with HSE carry 1 of 5 unique or extremely rare (minor allele frequency <0.001) missense TLR3 alleles. Two alleles (M374T, D592N) heterozygous in 3 patients are not deleterious in vitro. The other 3 are deleterious via different mechanisms: G743D+R811I and L360P heterozygous in 2 patients are loss-of-function due to low levels of expression and lack of cleavage, respectively, and R867Q homozygous in 1 patient is hypomorphic. The 3 patients9 fibroblasts display impaired TLR3 responses and enhanced herpes simplex virus 1 susceptibility. Overall, TLR3 deficiency is therefore found in 6 (5%) of the 120 patients studied. There is high allelic heterogeneity, with 3 forms of autosomal dominant partial defect by negative dominance or haploinsufficiency, and 2 forms of autosomal recessive defect with complete or partial deficiency. Finally, 4 (66%) of the 6 TLR3-deficient patients had at least 1 late relapse of HSE, whereas relapse occurred in only 12 (10%) of the total cohort of 120 patients. Conclusions: Childhood-onset HSE is due to TLR3 deficiency in a traceable fraction of patients, in particular the ones with HSE recurrence. Mutations in TLR3 and TLR3 pathway genes should be searched and experimentally studied in children with HSE, and patients with proven TLR3 deficiency should be followed carefully.

1 September 2017 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
MKMeri Kaustio
Meri Kaustio
EHEmma Haapaniemi
Emma Haapaniemi
HGHelka Göös
Helka Göös
THTimo Hautala
Timo Hautala
GPGiljun Park
Giljun Park
MSMikko Seppänen
Mikko Seppänen

17 March 2003 in The Journal of Gene Medicine
Verified
Journal Article
Closed access
PDF file
TTTatu Tarkka
Tatu Tarkka
ASAnnina Sipola
Annina Sipola
TJTimo Jämsä
Timo Jämsä
YSYlermi Soini
Ylermi Soini
Seppo Ylä-HerttualaSeppo Ylä-Herttuala
Seppo Ylä-Herttuala
THTimo Hautala
Timo Hautala

1 May 1992 in Genomics
Verified
Journal Article
Closed access
THTimo Hautala
Timo Hautala
MBMary G. Byers
Mary G. Byers
RERoger L. Eddy
Roger L. Eddy
TSThomas B. Shows
Thomas B. Shows
KKKari I. Kivirikko
Kari I. Kivirikko
RMRaili Myllyla
Raili Myllyla

1 April 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LTLuca Trotta
Luca Trotta
TMTimi Martelius
Timi Martelius
TSTimo Siitonen
Timo Siitonen
THTimo Hautala
Timo Hautala
SHSari Hämäläinen
Sari Hämäläinen
JSJanna Saarela
Janna Saarela

1 November 2016 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
LPLudmila Perelygina
Ludmila Perelygina
SPStanley Plotkin
Stanley Plotkin
PRPierre Russo
Pierre Russo
THTimo Hautala
Timo Hautala
FBFrancisco Bonilla
Francisco Bonilla
KSKathleen E. Sullivan
Kathleen E. Sullivan